Rosalind Advisors, Inc.
CIK: 0001622627SEC EDGAR →
Portfolio Value
$284.5M
Holdings
42
As of
Q4 2025
New Positions
8
Closed Positions
7
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | DELCATH SYSTEMS, INC. | 3,300,389 | $33.0M | 11.60% |
| 2 | SAVARA INC | 3,403,721 | $20.5M | 7.21% |
| 3 | FENNEC PHARMACEUTICALS INC | 2,613,508 | $20.1M | 7.07% |
| 4 | XERIS BIOPHARMA HOLDGS INC | 2,111,700 | $16.6M | 5.83% |
| 5 | VIRIDIAN THERAPEUTICS INC | 450,000 | $14.0M | 4.92% |
| 6 | MEDIWOUND LTD | 749,054 | $13.8M | 4.86% |
| 7 | VERASTEM INC | 1,788,475 | $13.8M | 4.85% |
| 8 | REPLIMUNE GROUP INC | 1,410,497 | $13.7M | 4.82% |
| 9 | ASTRIA THERAPEUTICS INC | 1,039,080 | $13.6M | 4.78% |
| 10 | CYBIN INC | 1,657,540 | $13.6M | 4.77% |
Quarterly Changes
New Positions (11)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 34 | $218.0M | 76.6% |
| Unknown | 5 | $53.1M | 18.7% |
| Financial Services | 3 | $13.3M | 4.7% |